Jacqueline Plowman

Chemistry · Physical Sciences

29h-index3.7kcitations73works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Synthesis and biological activity(13), Cancer therapeutics and mechanisms(13), Synthesis and Biological Evaluation(13), Biochemical and Molecular Research(11), HIV/AIDS drug development and treatment(8)

Publications73 total

Banf1 as a marker of lung cancer cell sensitivity to cisplatin
Lung Cancer·2019· 1 cited
Antiproliferative effect in vitro and antitumor activity in vivo of brefeldin A.
PubMed·2006· 32 cited
Human Tumor Xenograft Models in NCI Drug Development
Humana Press eBooks·1997· 218 cited
Preclinical antitumor activity of bizelesin in mice.
PubMed·1996· 22 cited
Antitumor 2,3-dihydro-2-(aryl)-4(1H)-quinazolinone derivatives
Biochemical Pharmacology·1996· 139 cited
Synthesis, antitumor activity, and chemical properties of silaplatin and related platinum(II) and platinum(IV) complexes derived from .beta.-silyl amines
Journal of Medicinal Chemistry·1995· 28 cited
Efficacy of the quinocarmycins KW2152 and DX-52-1 against human melanoma lines growing in culture kand in mice.
PubMed·1995· 25 cited
Reversal by cytidine of cyclopentenyl cytosine-induced toxicity in mice without compromise of antitumor activity
Biochemical Pharmacology·1995· 5 cited
Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea.
PubMed·1994· 132 cited
ChemInform Abstract: 2‐(Aminoalkyl)‐5‐nitropyrazolo(3,4,5‐kl)acridines, a New Class of Anticancer Agents.
ChemInform·1994
Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
PubMed·1994· 51 cited
Chloroquinoxaline sulfonamide: A sulfanilamide antitumor agent entering clinical trials
Investigational New Drugs·1993· 20 cited
2-(Aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agents
Journal of Medicinal Chemistry·1992· 50 cited
Preclinical antitumour activity and animal toxicology studies of rhizoxin, a novel tubulin-interacting agent
Annals of Oncology·1992· 35 citedOpen Access
L-histidinol: preclinical therapeutic studies in combination with antitumor agents and pharmacokinetic studies in mice.
PubMed·1992· 1 cited
Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice
Cancer Chemotherapy and Pharmacology·1992· 5 cited
Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analogs
Journal of Medicinal Chemistry·1991· 77 cited
Terephthalamidine: Past and future
Investigational New Drugs·1991· 2 cited
Practical spontaneous metastasis model for in vivo therapeutic studies using a human melanoma.
PubMed·1991· 23 cited
Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brain.
PubMed·1991· 16 cited
page 1 of 4Next →

Frequent Co-authors

Kenneth D. Paull(9), V. L. Narayanan(9), Donald J. Dykes(8), Brian Leyland‐Jones(6), Dale Shoemaker(6), Steadman D. Harrison(6), Charles K. Grieshaber(5), Daniel F. Hoth(4), John S. Driscoll(4), David A. Cooney(4), David G. Johns(4), Daniel P. Griswold(4), Daniel S. Zaharko(4), Peter J. O’Dwyer(4), Robert H. Shoemaker(3), William R. Waud(3), Frederick A. Valeriote(3), James C. Cradock(3), Louis Malspeis(3), Larry Rubinstein(2)